Local Institution

Tijuana, Estado de Baja California 22500

0 studies enrolling now · 18 studies all time

What they study most

Acute Coronary Syndrome, Arthritis, Rheumatoid, Atrial Fibrillation, Atrial Flutter, Deep Vein Thrombosis, Diabetes Mellitus, Diabetes Mellitus II, Diabetes Mellitus, Type 2, Metabolics Diabetes Nos, Prostatic Neoplasms, Pulmonary Embolism, Rheumatoid Arthritis

Studies at this site

• Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis — Completed
• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer — Completed
• Phase III Acute Coronary Syndrome — Stopped early
• Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery — Completed
• Methotrexate-Inadequate Response Study — Completed
• A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise — Completed
• Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis — Completed
• Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis — Completed
• Phase IIIB Switching From Intravenous to Subcutaneous Study — Completed
• Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3) — Completed
• Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism — Completed
• Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism — Completed
• PPAR - Combination With Metformin — Completed
• Dose Ranging Study With LT, Monotherapy, PPAR — Completed
• PPAR-COMBO With Sulfonylurea — Completed
• A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics — Completed
• Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone — Completed